United States: Meitheal Announces Exclusive Commercial Licensing Agreement For Insulin Biosimilars In The US - Goodwin Procter LLP

Meitheal Pharmaceuticals, Inc. ("Meitheal") has entered into an exclusive licensing deal with Tonghua Dongbao Pharmaceutical Co., Ltd. ("THDB") to market three insulin biosimilars...